TIM-4 Identifies IFN-γ–Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft Rejection

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Immunology

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1602107PMID 28848066PMCID PMC5726915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokine‐producing B cells: a translational view on their roles in human and mouse autoimmune diseases

  2016cited by this paper
• Pathogenic functions of B cells in autoimmune diseases: IFN‐γ production joins the criminal gang

  2015influential reference
• Antibody-independent functions of B cells: a focus on cytokines

  2015cited by this paper
• The expanding family of regulatory B cells

  2015cited by this paper
• B cells expressing IFN‐γ suppress Treg‐cell differentiation and promote autoimmune experimental arthritis

  2015cited by this paper
• Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth

  2015cited by this paper
• Tim-1 Is Essential for Induction and Maintenance of IL-10 in Regulatory B Cells and Their Regulation of Tissue Inflammation

  2015influential reference
• TIM‐1 Signaling Is Required for Maintenance and Induction of Regulatory B Cells

  2015cited by this paper
• The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.

  2014cited by this paper
• The phosphatidylserine receptor TIM4 utilizes integrins as coreceptors to effect phagocytosis

  2014cited by this paper
• Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.

  2014cited by this paper
• B10 cell regulation of health and disease

  2014cited by this paper
• B cells mediate chronic allograft rejection independently of antibody production.

  2014cited by this paper
• Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment

  2014cited by this paper
• Identification of IFN-γ-producing innate B cells

  2013influential reference
• Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma

  2013cited by this paper
• Interruption of Dendritic Cell–Mediated TIM-4 Signaling Induces Regulatory T Cells and Promotes Skin Allograft Survival

  2013cited by this paper
• B regulatory cells in cancer.

  2013cited by this paper
• Tumor-infiltrating B cells and T cells

  2012cited by this paper
• Two-Step Engulfment of Apoptotic Cells

  2011cited by this paper
• B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

  2011cited by this paper
• Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

  2011influential reference
• B Cells Help Alloreactive T Cells Differentiate Into Memory T Cells

  2010cited by this paper
• B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice

  2010influential reference
• TLR and B Cell Receptor Signals to B Cells Differentially Program Primary and Memory Th1 Responses to Salmonella enterica

  2010cited by this paper
• Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.

  2010cited by this paper
• PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

  2010cited by this paper
• CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes

  2010influential reference
• Effector and regulatory B cells: modulators of CD4+ T cell immunity

  2010cited by this paper
• T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice

  2010influential reference
• The phosphatidylserine receptor TIM-4 does not mediate direct signaling.

  2009cited by this paper
• B-cell-depleting induction therapy and acute cellular rejection.

  2009cited by this paper
• Regulatory B cells as inhibitors of immune responses and inflammation

  2008cited by this paper
• Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.

  2008cited by this paper
• A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

  2008cited by this paper
• Bimodal regulation of T cell-mediated immune responses by TIM-4.

  2008cited by this paper
• Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

  2008cited by this paper
• Suppression of Proteoglycan-Induced Arthritis by Anti-CD20 B Cell Depletion Therapy Is Mediated by Reduction in Autoantibodies and CD4+ T Cell Reactivity1

  2008cited by this paper
• Innate responses of B cells

  2007cited by this paper
• Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.

  2007cited by this paper
• TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

  2007cited by this paper
• Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

  2007cited by this paper
• Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse.

  2006cited by this paper
• B cell immunobiology in disease: evolving concepts from the clinic.

  2006cited by this paper
• Inhibitory effects of B cells on antitumor immunity.

  2006cited by this paper
• Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti‐tumor CTL and TH1 cytokine responses by B cells

  2005cited by this paper
• TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferation

  2005cited by this paper
• Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor.

  2005cited by this paper
• Regulation of IFN-γ Production by B Effector 1 Cells: Essential Roles for T-bet and the IFN-γ Receptor1

  2005cited by this paper
• Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

  2004cited by this paper
• Determination of subcutaneous tumor size in athymic (nude) mice

  2004cited by this paper
• Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.

  2002cited by this paper
• Reciprocal regulation of polarized cytokine production by effector B and T cells

  2000cited by this paper
• B cells inhibit induction of T cell-dependent tumor immunity

  1998cited by this paper
• CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2

  1995cited by this paper
• B cell development in mice that lack one or both immunoglobulin kappa light chain genes.

  1993cited by this paper
• The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.

  1990influential reference

• Infiltration of TIM4-positive intratumoral macrophages serves as an adverse prognostic factor in breast cancer

  2026cites this paper
• Emerging roles of checkpoint molecules on B cells

  2025cites this paper
• Subpopulações de células B em lesões de hanseníase: desvendando a complexa interação

  2025cites this paper
• B-cell subsets in leprosy lesions: unraveling the complex interplay

  2025cites this paper
• Cell therapies and its derivatives as immunomodulators in vascularized composite allotransplantation.

  2024cites this paper
• TIM proteins and microRNAs: distinct impact and promising interactions on transplantation immunity

  2024cites this paper
• Schistosoma mansoni egg-derived thioredoxin and Sm14 drive the development of IL-10 producing regulatory B cells

  2023cites this paper
• Probiotic neoantigen delivery vectors for precision cancer immunotherapy

  2023cites this paper
• Regulatory B Cells in Solid Organ Transplantation: From Immune Monitoring to Immunotherapy

  2023cites this paper
• TIM-4 Identifies Effector B Cells Expressing a RORγt-Driven Proinflammatory Cytokine Module That Promotes Immune Responsiveness

  2023cites this paper
• Recipient TIM4 signaling regulates ischemia reperfusion-induced ER stress and metabolic responses in liver transplantation: from mouse-to-human

  2023cites this paper
• Metabolites and Immune Response in Tumor Microenvironments

  2023cites this paper
• B-cell-specific checkpoint molecules that regulate anti-tumour immunity

  2023cites this paper
• B Cell IL-4 Drives Th2 Responses In Vivo, Ameliorates Allograft Rejection, and Promotes Allergic Airway Disease

  2022influential citation
• Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity

  2022cites this paper
• Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation

  2022cites this paper
• Function and characteristics of TIM-4 in immune regulation and disease (Review)

  2022cites this paper
• Transitional B cell cytokines predict renal allograft outcomes

  2021cites this paper
• Regulatory B cells: TIM‐1, transplant tolerance, and rejection

  2021cites this paper
• Immunosuppressive Mechanisms of Regulatory B Cells

  2021cites this paper
• Prolonged Allograft Survival in Immunocompromised Patients

  2020cites this paper
• Antigen‐dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs

  2020cites this paper
• Targeted Apoptosis of Ductular Reactive Cells Reduces Hepatic Fibrosis in a Mouse Model of Cholestasis

  2020cites this paper
• Tim-4 in Health and Disease: Friend or Foe?

  2020cites this paper
• Donor apoptotic cell–based therapy for effective inhibition of donor‐specific memory T and B cells to promote long‐term allograft survival in allosensitized recipients

  2020cites this paper
• B Cells in Immunity and Tolerance

  2020cites this paper
• Regulatory B Cells.

  2020cites this paper
• Effector B cells in cardiac allograft vasculopathy

  2019cites this paper
• Inhibition of TIM‐4 protects against cerebral ischaemia‐reperfusion injury

  2019cites this paper
• Costimulation Blockade in Transplantation.

  2019cites this paper
• An update on potentials and promises of T cell co‐signaling molecules in transplantation

  2019cites this paper
• Non-canonical B cell functions in transplantation.

  2019cites this paper
• Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection

  2019cites this paper
• Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes?

  2019cites this paper
• Regulatory and effector B cells: Friends or foes?

  2019cites this paper
• Regulatory B cells and transplantation: almost prime time?

  2018cites this paper
• Diverse roles of TIM4 in immune activation: implications for alloimmunity

  2017cites this paper